Marc-André Roy, M.D. - Publications

Affiliations: 
Medecine Laval University, Quebec, Ville de Québec, Québec, Canada 
Area:
Psychiatry

88/230 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Achim AM, Thibaudeau É, Huot A, Cellard C, Roy MA. What areas of everyday functioning are affected by theory of mind deficits in recent-onset schizophrenia spectrum disorders? Early Intervention in Psychiatry. PMID 35411646 DOI: 10.1111/eip.13291  0.312
2020 Corbeil O, Corbeil S, Giroux I, Jacques C, Dorval M, Demers MF, Roy MA. Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports. Journal of Clinical Psychopharmacology. 40: 191-194. PMID 32134855 DOI: 10.1097/Jcp.0000000000001177  0.377
2020 Corbeil O, Essiambre A, Rosebush-Mercier R, Rhéaume G, Demers M, Roy M. M197. Seasonal Antipsychotics In Schizophrenia: Outcomes In Naturalistic Settings (Seasons Study) Observational Retrospective Multicentre Canadian Study On 3Month-Formulation Of Long-Acting Injectable Paliperidone Palmitate Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.509  0.349
2020 Roy M, Gilbert E, Maziade M, Marquet P. T26. VISUO-TACTILE TRANSFER AND AUDIO-VISUAL INTEGRATION IMPAIRMENT AS A NEW VULNERABILITY MARKER IN CHILDREN-AT-RISK OF SCHIZOPHRENIA, BIPOLAR DISORDER OR RECURRENT DEPRESSIVE DISORDER Schizophrenia Bulletin. 46: S241-S241. DOI: 10.1093/schbul/sbaa029.586  0.713
2019 Chagnon YC, Maziade M, Paccalet T, Croteau J, Fournier A, Roy MA, Bureau A. A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds. European Journal of Human Genetics : Ejhg. PMID 31695175 DOI: 10.1038/S41431-019-0526-Y  0.305
2019 Pothier W, Cellard C, Corbière M, Villotti P, Achim AM, Lavoie A, Turcotte M, Vallières C, Roy MA. Determinants of occupational outcome in recent-onset psychosis: The role of cognition. Schizophrenia Research. Cognition. 18: 100158. PMID 31463205 DOI: 10.1016/J.Scog.2019.100158  0.303
2019 Lachance A, Corbeil O, Corbeil S, Chalifour G, Breault AS, Roy MA, Demers MF. Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence. Journal of Clinical Psychopharmacology. PMID 31206391 DOI: 10.1097/Jcp.0000000000001068  0.384
2019 Stip E, Abdel-Baki A, Roy MA, Bloom D, Grignon S. [Long-acting antipsychotics: The QAAPAPLE algorithm review]. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743719847193. PMID 31088133 DOI: 10.1177/0706743719847193  0.301
2019 Roy M, Strippoli M, Hébert M, Preisig M, Marquet P. T7. ELECTRORETINOGRAPHY FOR MAJOR PSYCHIATRIC DISORDERS IN MULTICENTRIC SITES Schizophrenia Bulletin. 45: S205-S206. DOI: 10.1093/SCHBUL/SBZ019.287  0.696
2018 Roy MA, Vallières C, Lehoux C, Leclerc LD, Demers MF, Achim AM. More intensive probing increases the detection of social anxiety disorders in schizophrenia. Psychiatry Research. 268: 358-360. PMID 30099275 DOI: 10.1016/J.Psychres.2018.07.032  0.345
2018 Roy MA, Demers MF, Achim AM. Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity. Journal of Psychiatry & Neuroscience : Jpn. 43: 287-288. PMID 29947611 DOI: 10.1503/Jpn.180081  0.385
2018 Roy M, Strippoli M, Vandeleur C, Gilbert E, Castelao E, Aubry J, Marquet P, Preisig M. F89. COGNITIVE IMPAIRMENT WORSENING ACROSS AFFECTIVE TO PSYCHOSIS SPECTRUM: A COHORT STUDY OF UNIPOLAR/BIPOLAR DEPRESSION AND BIPOLAR SCHIZOAFFECTIVE DISORDERS Schizophrenia Bulletin. 44: S254-S254. DOI: 10.1093/SCHBUL/SBY017.620  0.711
2017 Roy M, Gilbert E. SU108. Back to Basics of Basic Symptoms Concept: Which Phenomenon Scales Measure? Schizophrenia Bulletin. 43: S200-S200. DOI: 10.1093/schbul/sbx024.104  0.675
2016 Williams R, Malla A, Roy MA, Joober R, Manchanda R, Tibbo P, Banks N, Agid O. What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada? Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27310245 DOI: 10.1177/0706743716651049  0.306
2015 Cellard C, Rouleau N, Moreau I, Gilbert E, Paccalet T, Roy MA, Jomphe V, Mérette C, Maziade M. Cognitive structure from childhood to adulthood in kindreds densely affected by schizophrenia and bipolar disorder. Psychiatry Research. PMID 26233828 DOI: 10.1016/J.Psychres.2015.07.063  0.383
2015 Roy MA, Achim AM, Vallières C, Labbé A, Mérette C, Maziade M, Demers MF, Bouchard RH. Comorbidity between anxiety disorders and recent-onset psychotic disorders. Schizophrenia Research. 166: 353-4. PMID 26004685 DOI: 10.1016/J.Schres.2015.04.041  0.32
2015 Masson M, Wykes T, Maziade M, Reeder C, Gariépy MA, Roy MA, Ivers H, Cellard C. Top-down computerized cognitive remediation in schizophrenia: a case study of an individual with impairment in verbal fluency. Case Reports in Psychiatry. 2015: 242364. PMID 25949840 DOI: 10.1155/2015/242364  0.311
2015 Sutliff S, Roy MA, Achim AM. Social anxiety disorder in recent onset schizophrenia spectrum disorders: The relation with symptomatology, anxiety, and social rank. Psychiatry Research. 227: 39-45. PMID 25818255 DOI: 10.1016/J.Psychres.2015.02.017  0.376
2014 Gilbert E, Mérette C, Jomphe V, Emond C, Rouleau N, Bouchard RH, Roy MA, Paccalet T, Maziade M. Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment. European Archives of Psychiatry and Clinical Neuroscience. 264: 333-43. PMID 24173295 DOI: 10.1007/S00406-013-0463-7  0.347
2014 Sutliff SA, Roy M, Achim A. Poster #T226 SOCIAL ANXIETY DISORDER IN RECENT-ONSET SCHIZOPHRENIA SPECTRUM DISORDERS: THE RELATION WITH SYMPTOMOLOGY, ANXIETY, AND SOCIAL RANK Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)71042-4  0.354
2013 Manchanda R, Chue P, Malla A, Tibbo P, Roy MA, Williams R, Iyer S, Lutgens D, Banks N. Long-acting injectable antipsychotics: evidence of effectiveness and use. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 58: 5S-13S. PMID 23945067 DOI: 10.1177/088740341305805S02  0.352
2013 Malla A, Chue P, Jordan G, Stip E, Koczerginski D, Milliken H, Joseph A, Williams R, Adams B, Manchanda R, Oyewumi K, Roy MA. An Exploratory Open-Label Randomized Trial Comparing Risperidone Long Acting Injectable (RLAI) with Oral Antipsychotic Medication in the Treatment of Early Psychosis. Clinical Schizophrenia & Related Psychoses. 1-26. PMID 23773886 DOI: 10.3371/Csrp.Mach.061213  0.346
2013 D'Astous M, Cottin S, Roy M, Picard C, Cantin L. Bilateral stereotactic anterior capsulotomy for obsessive-compulsive disorder: long-term follow-up. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1208-13. PMID 23733922 DOI: 10.1136/Jnnp-2012-303826  0.691
2013 Achim AM, Ouellet R, Lavoie MA, Vallières C, Jackson PL, Roy MA. Impact of social anxiety on social cognition and functioning in patients with recent-onset schizophrenia spectrum disorders. Schizophrenia Research. 145: 75-81. PMID 23415473 DOI: 10.1016/J.Schres.2013.01.012  0.357
2012 Bureau A, Croteau J, Mérette C, Fournier A, Chagnon YC, Roy MA, Maziade M. Detection of phenotype modifier genes using two-locus linkage analysis in complex disorders such as major psychosis. Human Heredity. 73: 195-207. PMID 22907187 DOI: 10.1159/000341392  0.317
2012 Roy M, Grondin S, Roy MA. Time perception disorders are related to working memory impairment in schizophrenia. Psychiatry Research. 200: 159-66. PMID 22862910 DOI: 10.1016/J.Psychres.2012.06.008  0.773
2012 Labbe A, Bureau A, Moreau I, Roy MA, Chagnon Y, Maziade M, Merette C. Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder. European Journal of Human Genetics : Ejhg. 20: 1182-8. PMID 22535187 DOI: 10.1038/Ejhg.2012.67  0.359
2012 Kisely S, Ligate L, Roy MA, Lavery T. Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. 20: 138-42. PMID 22467557 DOI: 10.1177/1039856212437257  0.303
2011 Stip E, Abdel-Baki A, Bloom D, Grignon S, Roy MA. [Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec]. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 56: 367-76. PMID 21756451 DOI: 10.1177/070674371105600608  0.371
2011 Maziade M, Rouleau N, Cellard C, Battaglia M, Paccalet T, Moreau I, Gagnon V, Gingras N, Marino C, Gilbert E, Roy MA, Mérette C. Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time. Plos One. 6: e19153. PMID 21559460 DOI: 10.1371/Journal.Pone.0019153  0.354
2011 Marois MJ, Gingras N, Provencher MD, Mérette C, Emond C, Bourbeau J, Jomphe V, Roy MA. [Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting]. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 56: 51-61. PMID 21324243 DOI: 10.1177/070674371105600109  0.31
2011 Achim AM, Lefèbvre AA, Cellard C, Bouchard RH, Roy MA, Tremblay S. The role of recollection in source memory: an examination of schizophrenia patients and their first-degree relatives. Brain and Cognition. 75: 147-53. PMID 21134707 DOI: 10.1016/J.Bandc.2010.11.002  0.314
2011 Achim AM, Ouellet R, Roy MA, Jackson PL. Assessment of empathy in first-episode psychosis and meta-analytic comparison with previous studies in schizophrenia. Psychiatry Research. 190: 3-8. PMID 21131057 DOI: 10.1016/J.Psychres.2010.10.030  0.422
2011 Maziade M, Rouleau N, Mérette C, Cellard C, Battaglia M, Marino C, Jomphe V, Gilbert E, Achim A, Bouchard RH, Paccalet T, Paradis ME, Roy MA. Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories. Schizophrenia Bulletin. 37: 1218-28. PMID 20410238 DOI: 10.1093/Schbul/Sbq026  0.347
2011 Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophrenia Bulletin. 37: 811-21. PMID 19959704 DOI: 10.1093/Schbul/Sbp148  0.378
2010 Cellard C, Lefèbvre AA, Maziade M, Roy MA, Tremblay S. An examination of the relative contribution of saturation and selective attention to memory deficits in patients with recent-onset schizophrenia and their unaffected parents. Journal of Abnormal Psychology. 119: 60-70. PMID 20141243 DOI: 10.1037/A0018397  0.375
2010 Poirier S, Legris G, Tremblay P, Michea R, Viau-Guay L, Mérette C, Bouchard RH, Maziade M, Roy MA. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse. Schizophrenia Research. 118: 285-91. PMID 20096540 DOI: 10.1016/J.Schres.2009.12.036  0.351
2010 Lefèbvre AA, Cellard C, Tremblay S, Achim A, Rouleau N, Maziade M, Roy MA. Familiarity and recollection processes in patients with recent-onset schizophrenia and their unaffected parents. Psychiatry Research. 175: 15-21. PMID 19945175 DOI: 10.1016/J.Psychres.2009.01.007  0.331
2010 Hébert M, Gagné AM, Paradis ME, Jomphe V, Roy MA, Mérette C, Maziade M. Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders. Biological Psychiatry. 67: 270-4. PMID 19833322 DOI: 10.1016/J.Biopsych.2009.08.016  0.363
2010 Roy M, Achim A, Bouchard R, Raymond É, Mérette C, Maziade M. The Prevalence Of Anxiety Disorders In Schizophrenia. A Meta-Analysis And Critical Review On A Significant Association Schizophrenia Research. 117: 417-418. DOI: 10.1016/J.Schres.2010.02.765  0.396
2010 Maziade M, Rouleau N, Mérette C, Battaglia M, Marino C, Jomphe V, Gilbert E, Cellard C, Achim A, Bouchard R, Paradis M, Roy M. Verbal And Visual Memory Impairments Amongst Young Offspring And Healthy Adult Relatives Of Patients With Schizophrenia And Bipolar-Depression: Selective Generational Patterns Indicate Different Predictive Pathways Schizophrenia Research. 117: 202-202. DOI: 10.1016/J.Schres.2010.02.273  0.353
2009 Cellard C, Tremblay S, Lefébvre AA, Laplante L, Achim AM, Bouchard RH, Roy MA. Insights from the examination of verbal and spatial memory errors in relation to clinical symptoms of patients with recent-onset schizophrenia. Cognitive Neuropsychiatry. 14: 542-58. PMID 19894146 DOI: 10.1080/13546800903272059  0.335
2009 Bureau A, Mérette C, Croteau J, Fournier A, Chagnon YC, Roy MA, Maziade M. A new strategy for linkage analysis under epistasis taking into account genetic heterogeneity. Human Heredity. 68: 231-42. PMID 19622890 DOI: 10.1159/000228921  0.325
2009 Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE, Irmansyah, Holmans PA, Escamilla M, Wildenauer DB, Williams NM, Laurent C, ... ... Roy MA, et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry. 14: 774-85. PMID 19349958 DOI: 10.1038/Mp.2008.135  0.594
2009 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Andreasen NC, Brady KT, Brent DA, Brzustowicz L, Carter CS, Eisenberg L, Goldman H, Javitt DC, Leibenluft E, ... ... Roy MD, et al. Conflict of interest-- an issue for every psychiatrist. The American Journal of Psychiatry. 166: 274. PMID 19255048 DOI: 10.1176/Appi.Ajp.2009.09010093  0.338
2009 Maziade M, Chagnon YC, Roy MA, Bureau A, Fournier A, Mérette C. Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype. European Journal of Human Genetics : Ejhg. 17: 1034-42. PMID 19172987 DOI: 10.1038/Ejhg.2008.268  0.36
2009 Maziade M, Rouleau N, Gingras N, Boutin P, Paradis ME, Jomphe V, Boutin J, Létourneau K, Gilbert E, Lefebvre AA, Doré MC, Marino C, Battaglia M, Mérette C, Roy MA. Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families. Schizophrenia Bulletin. 35: 919-30. PMID 18550590 DOI: 10.1093/Schbul/Sbn058  0.418
2008 Roy M, Roy MA, Grondin S. [Perturbed consciousness in schizophrenia: an evaluation of C.D. Frith's model]. L'Encephale. 34: 369-75. PMID 18922239 DOI: 10.1016/J.Encep.2007.08.007  0.748
2008 Potvin S, Kouassi E, Lipp O, Bouchard RH, Roy MA, Demers MF, Gendron A, Astarita G, Piomelli D, Stip E. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. Journal of Psychopharmacology (Oxford, England). 22: 262-9. PMID 18308802 DOI: 10.1177/0269881107083816  0.422
2008 Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. The American Journal of Drug and Alcohol Abuse. 34: 75-82. PMID 18161645 DOI: 10.1080/00952990701764631  0.362
2007 Cellard C, Tremblay S, Lehoux C, Roy MA. Processing spatial-temporal information in recent-onset schizophrenia: the study of short-term memory and its susceptibility to distraction. Brain and Cognition. 64: 201-7. PMID 17462806 DOI: 10.1016/J.Bandc.2007.03.001  0.353
2007 Szatmari P, Maziade M, Zwaigenbaum L, Mérette C, Roy MA, Joober R, Palmour R. Informative phenotypes for genetic studies of psychiatric disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 581-8. PMID 17219386 DOI: 10.1002/Ajmg.B.30426  0.355
2006 Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Current Medical Research and Opinion. 22: 1277-85. PMID 16834826 DOI: 10.1185/030079906X112561  0.412
2006 Lefebvre AA, Cellard C, Tremblay S, Roy MA. A comment on "Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis" from a cognitive neuropsychological perspective. Schizophrenia Research. 84: 170-1. PMID 16631356 DOI: 10.1016/J.Schres.2006.02.026  0.357
2005 Lehoux C, Lefebvre AA, Létourneau K, Viau H, Gosselin D, Szatmari P, Bouchard RH, Maziade M, Roy MA. A pilot feasibility study of an extension of the acquaintanceship recruitment procedure in recent-onset psychosis. The Journal of Nervous and Mental Disease. 193: 560-3. PMID 16082301 DOI: 10.1097/01.Nmd.0000172680.18302.80  0.317
2005 Grondin S, Roussel ME, Gamache PL, Roy M, Ouellet B. The structure of sensory events and the accuracy of time judgments. Perception. 34: 45-58. PMID 15773606 DOI: 10.1068/P5369  0.719
2005 Bérubé F, Roy M. Dopamine in the Pathophysiology and Treatment of Schizophrenia: New Findings American Journal of Psychiatry. 162: 2204-2205. DOI: 10.1176/Ajp.162.11.2204-A  0.352
2003 Maziade M, Mérette C, Chagnon YC, Roy MA. [Genetics of schizophrenia and bipolar disorder: recent success of linkage studies with evidence of specific and shared susceptibility loci]. Medecine Sciences : M/S. 19: 960-6. PMID 14613007 DOI: 10.1051/Medsci/20031910960  0.411
2003 Roy MA, Lehoux C, Emond C, Laplante L, Bouchard RH, Everett J, Mérette C, Maziade M. A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia. Schizophrenia Research. 62: 155-63. PMID 12765756 DOI: 10.1016/S0920-9964(02)00481-4  0.394
2003 Roy M, Cayer M, Lehoux C, Palmour R, Trepanier J, Pelletier S, Rene´ L, Szatmari P, Bouchard R, Merette M, Maziade M. Depressive symptoms and course identify two distinct clusters within very poor outcome schizophrenia Schizophrenia Research. 60: 7. DOI: 10.1016/S0920-9964(03)80017-8  0.332
2002 Marois MJ, Roy MA. Haloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia. Evidence-Based Mental Health. 5: 113. PMID 12440454 DOI: 10.1136/Ebmh.5.4.113  0.365
2002 Maziade M, Fournier A, Phaneuf D, Cliche D, Fournier JP, Roy MA, Mérette C. Chromosome 1q12-q22 linkage results in eastern Québec families affected by schizophrenia. American Journal of Medical Genetics. 114: 51-5. PMID 11840506 DOI: 10.1002/Ajmg.1616  0.331
2002 Roy M. Negative Symptom and Cognitive Deficit Treatment Response in Schizophrenia American Journal of Psychiatry. 159: 683-683. DOI: 10.1176/Appi.Ajp.159.4.683  0.38
2001 Roy M, Maziade M, Labbé A, Mérette C. Male gender is associated with deficit schizophrenia: a meta-analysis. Schizophrenia Research. 47: 141-147. PMID 11278131 DOI: 10.1016/S0920-9964(99)00231-5  0.388
2001 Roy M, Mérette C, Maziade M. Subtyping Schizophrenia According to Outcome or Severity: A Search for Homogeneous Subgroups Schizophrenia Bulletin. 27: 115-138. PMID 11215541 DOI: 10.1093/Oxfordjournals.Schbul.A006851  0.382
2000 Maziade M, Mérette C, Cayer M, Roy M, Szatmari P, Côté R, Thivierge J. Prolongation of Brainstem Auditory-Evoked Responses in Autistic Probands and Their Unaffected Relatives Archives of General Psychiatry. 57: 1077-1083. PMID 11074874 DOI: 10.1001/Archpsyc.57.11.1077  0.308
2000 Merette C, Brassard A, Potvin A, Bouvier H, Rousseau F, Edmond C, Bissonnette L, Roy MA, Maziade M, Ott J, Caron C. Significant linkage for tourette syndrome in a large French Canadian family American Journal of Human Genetics. 67: 1008-1013. PMID 10986045 DOI: 10.1086/303093  0.312
2000 Bouchard RH, Mérette C, Pourcher E, Demers MF, Villeneuve J, Roy-Gagnon MH, Gauthier Y, Cliche D, Labelle A, Filteau MJ, Roy MA, Maziade M. Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group. Journal of Clinical Psychopharmacology. 20: 295-304. PMID 10831015 DOI: 10.1097/00004714-200006000-00002  0.385
2000 Mérette C, Roy-Gagnon MH, Ghazzali N, Savard F, Boutin P, Roy MA, Maziade M. Anticipation in schizophrenia and bipolar disorder controlling for an information bias. American Journal of Medical Genetics. 96: 61-8. PMID 10686554 DOI: 10.1002/(Sici)1096-8628(20000207)96:1<61::Aid-Ajmg13>3.0.Co;2-W  0.402
2000 Roy M. Schizophrenia in a Molecular Age American Journal of Psychiatry. 157: 1897-1897. DOI: 10.1176/Appi.Ajp.157.11.1897  0.354
1997 Roy MA, Neale MC, Kendler KS. Selecting a control group in studies of the familial coaggregation of two disorders: a quantitative genetics perspective. American Journal of Medical Genetics. 74: 296-303. PMID 9184314 DOI: 10.1002/(Sici)1096-8628(19970531)74:3<296::Aid-Ajmg11>3.0.Co;2-J  0.407
1997 Maziade M, Martinez M, Rodrigue C, Gauthier B, Tremblay G, Fournier C, Bissonnette L, Simard C, Roy M, Rouillard E, Mérette C. Childhood/early adolescence-onset and adult-onset schizophrenia. Heterogeneity at the dopamine D3 receptor gene. British Journal of Psychiatry. 170: 27-30. PMID 9068771 DOI: 10.1192/Bjp.170.1.27  0.387
1997 Roy M, Maziade M. Very poor outcome schizophrenia: A pilot study Schizophrenia Research. 24: 257. DOI: 10.1016/S0920-9964(97)82741-7  0.357
1997 Maziade M, Roy M, Martinez M, Gauthier B, Tremblay G, Fournier C, Bissonnette L, Simard C, Rouillard E, Mérette C. Childhood-early adolescence onset and adult onset schizophrenia: Heterogeneity at the dopamine D3 receptor gene Schizophrenia Research. 24: 92. DOI: 10.1016/S0920-9964(97)82249-9  0.314
1996 Maziade M, Bouchard S, Gingras N, Charron L, Cardinal A, Roy MA, Gauthier B, Tremblay G, Côté S, Fournier C, Boutin P, Hamel M, Mérette C, Martinez M. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome. The British Journal of Psychiatry : the Journal of Mental Science. 169: 371-8. PMID 9004982 DOI: 10.1192/Bjp.169.3.371  0.363
1996 Maziade M, Gingras N, Rodrigue C, Bouchard S, Cardinal A, Gauthier B, Tremblay G, Côté S, Fournier C, Boutin P, Hamel M, Roy M, Martinez M, Mérette C. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onset. British Journal of Psychiatry. 169: 361-370. PMID 8879724 DOI: 10.1192/Bjp.169.3.361  0.387
1996 Roy MA, Walsh D, Kendler KS. Accuracies and inaccuracies of the family history method: a multivariate approach. Acta Psychiatrica Scandinavica. 93: 224-34. PMID 8712019 DOI: 10.1111/j.1600-0447.1996.tb10639.x  0.386
1996 Bouchard S, Vallières A, Roy M, Maziade M. Cognitive restructuring in the treatment of psychotic symptoms in schizophrenia: A critical analysis Behavior Therapy. 27: 257-277. DOI: 10.1016/S0005-7894(96)80017-7  0.415
1995 Roy MA, Flaum M, Andreasen NC. No difference found between winter- and non-winter-born schizophrenic cases. Schizophrenia Research. 17: 241-8. PMID 8664203 DOI: 10.1016/0920-9964(95)00010-0  0.457
1995 Roy MA, Neale MC, Pedersen NL, Mathé AA, Kendler KS. A twin study of generalized anxiety disorder and major depression. Psychological Medicine. 25: 1037-49. PMID 8588001 DOI: 10.1017/S0033291700037533  0.354
1995 Roy MA, Neale MC, Kendler KS. The genetic epidemiology of self-esteem. The British Journal of Psychiatry : the Journal of Mental Science. 166: 813-20. PMID 7663835 DOI: 10.1192/Bjp.166.6.813  0.361
1995 Kendler KS, Roy MA. Validity of a diagnosis of lifetime major depression obtained by personal interview versus family history. The American Journal of Psychiatry. 152: 1608-14. PMID 7485623 DOI: 10.1176/Ajp.152.11.1608  0.387
1994 Roy MA, Flaum MA, Gupta S, Jaramillo L, Andreasen NC. Epidemiological and clinical correlates of familial and sporadic schizophrenia. Acta Psychiatrica Scandinavica. 89: 324-8. PMID 8067271 DOI: 10.1111/J.1600-0447.1994.Tb01523.X  0.466
1994 Roy M, Devriendt X. Symptômes Positifs Et Négatifs De La Schizophrénie: Une Mise à jour*: The Canadian Journal of Psychiatry. 39: 407-414. PMID 7987782 DOI: 10.1177/070674379403900704  0.339
1994 Roy MA, Walsh D, Prescott CA, Kendler KS. Biases in the diagnosis of alcoholism by the family history method Alcoholism: Clinical and Experimental Research. 18: 845-851. PMID 7978094 DOI: 10.1111/J.1530-0277.1994.Tb00049.X  0.389
1994 Roy MA, Kendler KS. The effect of diagnostic hierarchy in genetic epidemiological studies of psychiatric disorders. Archives of General Psychiatry. 51: 926-7. PMID 7944881 DOI: 10.1001/Archpsyc.1994.03950110086011  0.434
1994 Roy MA, Flaum MA, Arndt SV, Crowe RR, Andreasen NC. Magnetic resonance imaging in familial versus sporadic cases of schizophrenia. Psychiatry Research. 54: 25-36. PMID 7701026 DOI: 10.1016/0165-1781(94)90062-0  0.509
1993 Maziade M, Debraekeleer M, Genest P, Cliche D, Fournier JP, Garneau Y, Shriqui C, Roy MA, Nicole L, Raymond V, Vekemans M. A Balanced 2:18 Translocation and Familial Schizophrenia: Falling Short of an Association Archives of General Psychiatry. 50: 73-75. PMID 8422227 DOI: 10.1001/Archpsyc.1993.01820130079017  0.4
Low-probability matches (unlikely to be authored by this person)
2023 Cayouette A, Thibaudeau É, Cellard C, Roy MA, Achim AM. Associations between theory of mind and clinical symptoms in recent onset schizophrenia spectrum disorders. Frontiers in Psychiatry. 14: 1044682. PMID 36846242 DOI: 10.3389/fpsyt.2023.1044682  0.298
2020 Nolin MA, Demers MF, Rauzier C, Bouchard RH, Cadrin C, Després JP, Roy MA, Alméras N, Picard F. Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-8. PMID 32552257 DOI: 10.1080/15622975.2020.1770858  0.296
2019 Roy M, Cellard C, Corbière M, Villotti P, Achim AM, Lavoie A, Turcotte M, Vallières C. T50. Determinants Of Occupational Recovery In Recent-Onset Psychosis: The Role Of Cognition Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz019.330  0.293
2012 Oualkacha K, Labbe A, Ciampi A, Roy MA, Maziade M. Principal components of heritability for high dimension quantitative traits and general pedigrees. Statistical Applications in Genetics and Molecular Biology. 11. PMID 22499698 DOI: 10.2202/1544-6115.1711  0.292
2002 Szatmari P, Mérette C, Bryson SE, Thivierge J, Roy MA, Cayer M, Maziade M. Quantifying dimensions in autism: a factor-analytic study. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 467-74. PMID 11931604 DOI: 10.1097/00004583-200204000-00020  0.287
2013 Malla A, Tibbo P, Chue P, Levy E, Manchanda R, Teehan M, Williams R, Iyer S, Roy MA. Long-acting injectable antipsychotics: recommendations for clinicians. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 58: 30S-5S. PMID 23945065 DOI: 10.1177/088740341305805S05  0.287
2007 L'Heureux S, Nicole L, Abdel-Baki A, Roy MA, Gingras N, Demers MF. [Improving detection and treatment of early psychosis in Québec: the Quebec association of early psychosis (l'Association québécoise des programmes pour premiers épisodes psychotiques, AQPPEP), sees to it]. Santé Mentale Au QuéBec. 32: 299-315. PMID 18253673 DOI: 10.7202/016522Ar  0.285
2022 Brodeur S, Vanasse A, Courteau J, Stip E, Lesage A, Fleury MJ, Courteau M, Roy MA. Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study. Acta Psychiatrica Scandinavica. PMID 35158404 DOI: 10.1111/acps.13413  0.281
2013 Iyer S, Banks N, Roy MA, Tibbo P, Williams R, Manchanda R, Chue P, Malla A. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 58: 23S-9S. PMID 23945064 DOI: 10.1177/088740341305805S04  0.281
2012 Achim AM, Ouellet R, Roy MA, Jackson PL. Mentalizing in first-episode psychosis. Psychiatry Research. 196: 207-13. PMID 22377576 DOI: 10.1016/J.Psychres.2011.10.011  0.278
2014 Achim AM, Roy M, Lavoie M, Jackson P. Poster #T3 PREDICTORS OF THEORY OF MIND AND SOCIAL FUNCTIONING IMPAIRMENTS IN PATIENTS WITH RECENT-ONSET OF PSYCHOSIS Schizophrenia Research. 153: S289-S290. DOI: 10.1016/S0920-9964(14)70820-5  0.277
2001 Roy M, Gingras N. Self reported symptoms in children predicted schizophreniform disorder as adults Evidence-Based Mental Health. 4: 95-95. DOI: 10.1136/Ebmh.4.3.95  0.277
2020 Roy MA. The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720901975. PMID 32030998 DOI: 10.1177/0706743720901975  0.273
2004 Alméras N, Després JP, Villeneuve J, Demers MF, Roy MA, Cadrin C, Mottard JP, Bouchard RH. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. The Journal of Clinical Psychiatry. 65: 557-64. PMID 15119921 DOI: 10.4088/Jcp.V65N0417  0.272
2013 Bastille-Denis E, Roy M, Vallières A. The presence and the nature of dysfunctional cognitions and the focus of attention during pre-sleep period in shift workers Sleep Medicine. 14. DOI: 10.1016/J.Sleep.2013.11.137  0.272
2019 Nolin M, Rauzier C, Alméras N, Després J, Roy M, Bouchard R, Demers M, Picard F. F5. Circulating Igfbp-2 Levels Reveal Atherogenic Metabolic Risk In Schizophrenic Patients Using Atypical Antipsychotics Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz018.417  0.271
2019 Tremblay M, Rioux S, Fraser C, Bouffard A, L’Heureux S, Vallières C, Demers M, Roy M. S110. Long-Acting Aripiprazole In First-Episode Psychosis: Does One Size Fit All? Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz020.655  0.268
2022 Achim AM, Roy MA, Fossard M. The other side of the social interaction: Theory of mind impairments in people with schizophrenia are linked to other people's difficulties in understanding them. Schizophrenia Research. PMID 35906170 DOI: 10.1016/j.schres.2022.07.001  0.266
2008 Mérette C, Roy MA, Bureau A, Fournier A, Emond C, Cliche D, Jomphe V, Chagnon YC, Maziade M. Replication of linkage with bipolar disorder on chromosome 16p in the Eastern Quebec population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 737-44. PMID 18165973 DOI: 10.1002/Ajmg.B.30673  0.264
2008 Blouin M, Tremblay A, Jalbert ME, Venables H, Bouchard RH, Roy MA, Alméras N. Adiposity and eating behaviors in patients under second generation antipsychotics. Obesity (Silver Spring, Md.). 16: 1780-7. PMID 18535555 DOI: 10.1038/Oby.2008.277  0.263
2023 Oluboka O, Clerzius G, Janetzky W, Schöttle D, Therrien F, Wiedemann K, Roy MA. Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study). Bmc Psychiatry. 23: 383. PMID 37259053 DOI: 10.1186/s12888-023-04893-8  0.26
2009 Lehoux C, Gobeil M, Lefèbvre A, Maziade M, Roy M. The Five-Factor Structure of the PANSS: A Critical Review of its Consistency Across Studies Clinical Schizophrenia & Related Psychoses. 3: 103-110. DOI: 10.3371/Csrp.3.2.5  0.26
2017 Carrier JD, Blais L, Cohen A, Courteau J, Roberge P, Larouche A, Grignon S, Fleury MJ, Lesage A, Demers MF, Roy MA, Delorme A, Vanasse A. [Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006]. Sante Mentale Au Quebec. 42: 85-103. PMID 28792563  0.259
1996 Pléchaty M, Couturier S, Côté M, Roy M, Massicotte J, Freeston MH. Dimensional Analysis of past and Present Satisfaction in Relation to Present Marital Satisfaction Psychological Reports. 78: 657-658. DOI: 10.2466/Pr0.1996.78.2.657  0.257
2019 Roy M, Antoine L. F114. The Evolution Of Long-Acting Antipsychotics Use In Quebec Between 2003 And 2017 Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz018.526  0.254
2005 Gaudreau JD, Gagnon P, Harel F, Roy MA. Impact on delirium detection of using a sensitive instrument integrated into clinical practice. General Hospital Psychiatry. 27: 194-9. PMID 15882766 DOI: 10.1016/J.Genhosppsych.2005.01.002  0.253
2008 Szatmari P, Mérette C, Emond C, Zwaigenbaum L, Jones MB, Maziade M, Roy MA, Palmour R. Decomposing the autism phenotype into familial dimensions. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 3-9. PMID 17520691 DOI: 10.1002/Ajmg.B.30561  0.252
2023 Corbeil O, Brodeur S, Courteau J, Béchard L, Huot-Lavoie M, Angelopoulos E, Di Stefano S, Marrone E, Vanasse A, Fleury MJ, Stip E, Lesage A, Joober R, Demers MF, Roy MA. Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting. The British Journal of Psychiatry : the Journal of Mental Science. 1-8. PMID 38044665 DOI: 10.1192/bjp.2023.149  0.251
2018 Roy MA, Doiron M, Talon-Croteau J, Dupré N, Simard M. Effects of Antiparkinson Medication on Cognition in Parkinson's Disease: A Systematic Review. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-30. PMID 29747716 DOI: 10.1017/Cjn.2018.21  0.25
2005 Gaudreau JD, Gagnon P, Harel F, Tremblay A, Roy MA. Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. Journal of Pain and Symptom Management. 29: 368-75. PMID 15857740 DOI: 10.1016/J.Jpainsymman.2004.07.009  0.249
2004 Poirier S, Bureau V, Lehoux C, Bouchard RH, Maziade M, Pelletier S, René L, Trépanier J, Émond C, Mérette, Roy MA. A factor analysis of the Strauss and Carpenter revised outcome criteria scale: A validation of the French translation Journal of Nervous and Mental Disease. 192: 864-867. PMID 15583509 DOI: 10.1097/01.Nmd.0000146880.91895.50  0.245
2022 Brodeur S, Vanasse A, Courteau J, Courteau M, Stip E, Fleury MJ, Lesage A, Demers MF, Roy MA. Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach. Acta Psychiatrica Scandinavica. PMID 35152415 DOI: 10.1111/acps.13411  0.245
2005 Gaudreau JD, Gagnon P, Harel F, Roy MA, Tremblay A. Psychoactive medications and risk of delirium in hospitalized cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6712-8. PMID 16170179 DOI: 10.1200/Jco.2005.05.140  0.245
2007 Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A. Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer. 109: 2365-73. PMID 17469164 DOI: 10.1002/Cncr.22665  0.244
2022 Brodeur S, Courteau J, Vanasse A, Courteau M, Stip E, Fleury MJ, Lesage A, Demers MF, Corbeil O, Béchard L, Roy MA. Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study. The British Journal of Psychiatry : the Journal of Mental Science. 1-8. PMID 35082000 DOI: 10.1192/bjp.2022.1  0.243
2019 Corbeil O, Corbeil S, Breault A, Chalifour G, Roy M, Demers M. O5.4. Problem Gambling Associated With Aripiprazole: A Nested Case-Control Study In A First-Episode Psychosis Cohort Using A Systematic Pharmacovigilance Approach Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz021.212  0.243
2020 Thibaudeau É, Pothier W, Lavoie A, Turcotte M, Achim AM, Vallières C, Roy M, Cellard C. M59. The Associations Between Theory Of Mind And Neurocognition In Recent Onset Psychosis Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.371  0.242
2022 Corbeil O, Essiambre AM, Béchard L, Roy AA, Huot-Lavoie M, Brodeur S, Chandrasena R, Thériault C, Crocker C, Melun JP, Tibbo P, Demers MF, Roy MA. Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation. Therapeutic Advances in Psychopharmacology. 12: 20451253221136021. PMID 36405400 DOI: 10.1177/20451253221136021  0.242
2009 Blouin M, Binet M, Bouchard RH, Roy MA, Després JP, Alméras N. Improvement of metabolic risk profile under second-generation antipsychotics: a pilot intervention study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 275-9. PMID 19321034 DOI: 10.1177/070674370905400409  0.242
2005 Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A. Association between psychoactive medications and delirium in hospitalized patients: a critical review. Psychosomatics. 46: 302-16. PMID 16000673 DOI: 10.1176/Appi.Psy.46.4.302  0.24
2014 Roy M, Pelletier B, Loiseau A, Harisson M. Poster #M241 DESCRIPTION OF THE IMPACTS OF CLOZAPINE USE IN AN EARLY STAGE PSYCHOSIS POPULATION Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70791-1  0.239
2015 Cellard C, Reeder C, Paradis-Giroux AA, Roy MA, Gilbert E, Ivers H, Bouchard RH, Maziade M, Wykes T. A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia. Neuropsychological Rehabilitation. 1-24. PMID 25753694 DOI: 10.1080/09602011.2015.1019891  0.237
2018 Demers MF, Fortier L, Corbeil O, Breault AS, Roy MA. Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use. Asian Journal of Psychiatry. PMID 30314715 DOI: 10.1016/J.Ajp.2018.10.005  0.236
1999 Mérette C, Cayer M, Rouillard E, Roy-Gagnon MH, Guibord P, Kovac I, Ghazzali N, Szatmari P, Roy MA, Maziade M, Palmour R. Evidence of linkage in subtypes of alcoholism. Genetic Epidemiology. 17: S253-8. PMID 10597445 DOI: 10.1002/Gepi.1370170743  0.232
2022 Corbeil O, Bérubé FA, Artaud L, Roy MA. [Detecting and Treating Comorbid Disorders in First-Episode Psychosis: A Lever for Recovery]. Sante Mentale Au Quebec. 46: 307-330. PMID 35617503  0.231
2022 Vanasse A, Courteau J, Courteau M, Roy MA, Stip E, Fleury MJ, Lesage A, Brodeur S. Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophrenia. Schizophrenia (Heidelberg, Germany). 8: 52. PMID 35854023 DOI: 10.1038/s41537-022-00256-6  0.223
2021 Leclerc LD, Demers MF, Bardell A, Bilodeau I, Williams R, Tibbo P, Roy MA. A Chart Audit Study of Clozapine Utilization in Early Psychosis. Journal of Clinical Psychopharmacology. PMID 33734165 DOI: 10.1097/JCP.0000000000001384  0.222
2020 Béchard L, Corbeil O, Plante M, Thivierge M, Lafrenière C, Roy M, Demers M. S1. Clozapine Rechallenge Following Neutropenia Using Granulocyte Colony-Stimulating Factor: A Quebec Case Series Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.067  0.22
2022 Béchard L, Morasse-Bégis M, Corbeil O, Hakim JR, Malenfant E, Brodeur S, Huot-Lavoie M, Essiambre AM, Demers MF, Roy MA. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series. Journal of Clinical Psychopharmacology. PMID 35546087 DOI: 10.1097/JCP.0000000000001556  0.217
2017 Demers M, Bilodeau I, Laberge L, Lavigne D, Tremblay G, Chalifour G, Lepage E, Roy M. SU112. The Dark Side of Haloperidol Decanoate Shortage in Canada Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx024.108  0.216
2013 Bureau A, Chagnon YC, Croteau J, Fournier A, Roy MA, Paccalet T, Mérette C, Maziade M. Follow-up of a major psychosis linkage site in 13q13-q14 reveals significant association in both case-control and family samples. Biological Psychiatry. 74: 444-50. PMID 23602252 DOI: 10.1016/j.biopsych.2013.03.004  0.214
2013 Bastille-Denis E, Roy M, Vallières A. Catastrophization process and themes of worry in shift workers Sleep Medicine. 14. DOI: 10.1016/J.Sleep.2013.11.138  0.214
2022 Béchard L, Corbeil O, Thivierge MA, Assaad I, Boulanger C, Mailhot MP, Turgeon-Fournier A, Roy MA, Demers MF. Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 20: 194-198. PMID 35078963 DOI: 10.9758/cpn.2022.20.1.194  0.206
2017 Carrier J, Blais L, Cohen A, Courteau J, Roberge P, Larouche A, Grignon S, Fleury M, Lesage A, Demers M, Roy M, Delorme A, Vanasse A. Amorcer un traitement antipsychotique en schizophrénie : la situation au Québec de 1998 à 2006 Santé Mentale Au QuéBec. 42: 85-103. DOI: 10.7202/1040245Ar  0.206
2014 Bertin J, Jalaguier P, Barat C, Roy MA, Tremblay MJ. Exposure of human astrocytes to leukotriene C4 promotes a CX3CL1/fractalkine-mediated transmigration of HIV-1-infected CD4⁺ T cells across an in vitro blood-brain barrier model. Virology. 454: 128-38. PMID 24725939 DOI: 10.1016/J.Virol.2014.02.007  0.206
2014 Demers M, Lévesque C, Bouchard J, Bourbeau J, Roy M. Poster #M192 THE DJ'S CHOICES APPROACH ADAPTED FOR FAMILIES Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70742-X  0.205
1997 Maziade M, Roy M, Bissonnette L, Martinez M, Cliche D, Fournier J, Montgrain N. Major psychoses and a potential vulnerability locus on 6p24-p22 in the Eastern Québec population Schizophrenia Research. 24: 52. DOI: 10.1016/S0920-9964(97)82147-0  0.204
2017 Roy M, Demers M, Achim A, Joober R, Banks N, Malla A, Bardell A, Williams R, Tibbo P. M112. Clozapine Use in Early-Intervention Programs Across Canada Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx022.107  0.203
1997 Roy M, Maziade M. Facfors associated with the reliability of the best-estimate diagnostic procedure Schizophrenia Research. 24: 7. DOI: 10.1016/S0920-9964(97)82017-8  0.201
2020 Gagnon P, Gaudreau JD, Roy MA, Le Moignan Moreau J. Letter to the Editor: Correction About the Nursing Delirium Screening Scale in Response to: "A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium". Psychosomatics. PMID 32654828 DOI: 10.1016/J.Psym.2020.05.019  0.201
2017 Deshiere A, Joly-Beauparlant C, Breton Y, Ouellet M, Raymond F, Lodge R, Barat C, Roy MA, Corbeil J, Tremblay MJ. Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin. Scientific Reports. 7: 5238. PMID 28701698 DOI: 10.1038/S41598-017-05566-9  0.2
2019 Roy M, Morasse-Bégin M, Malenfant E, Nadeau M, Breault A, Chalifour G, Essiambre A, Corbeil O, Marie-France D. O12.2. Clozapine Re-Challenge Or Continuation Following A Neutropenia: Case-Series Of 22 Cases Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz021.266  0.2
2024 Corbeil O, Anderson É, Béchard L, Desmeules C, Huot-Lavoie M, Bachand L, Brodeur S, Carmichael PH, Jacques C, Solmi M, Giroux I, Dorval M, Demers MF, Roy MA. Problem gambling in psychotic disorders: A systematic review and meta-analysis of prevalence. Acta Psychiatrica Scandinavica. PMID 38566334 DOI: 10.1111/acps.13686  0.2
2013 Canizales DL, Voisin JI, Michon PE, Roy MA, Jackson PL. The influence of visual perspective on the somatosensory steady-state response during pain observation. Frontiers in Human Neuroscience. 7: 849. PMID 24367323 DOI: 10.3389/Fnhum.2013.00849  0.196
2014 Demers M, Bourbeau J, Lévesque C, Gauthier L, Roy M. Poster #S194 ROLL-OUT AND IMPACTS OF DJ'S CHOICES WORKSHOPS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70473-6  0.195
2009 Hein R, Beckmann L, Chang-Claude J, Bureau A, Mérette C, Croteau J, Fournier A, Chagnon YC, Roy M, Maziade M, Ekstrøm CT, Bergemann TL, Huang Z, Cheng KF, Lin WJ, et al. Subject Index Vol. 68, 2009 Human Heredity. 68: 290-290. DOI: 10.1159/000243587  0.195
2021 Béchard L, Corbeil O, Plante M, Thivierge MA, Lafrenière CÉ, Roy MA, Demers MF. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series. Journal of Psychopharmacology (Oxford, England). 2698811211029737. PMID 34229529 DOI: 10.1177/02698811211029737  0.193
2003 Lehoux C, Everett J, Laplante L, Emond C, Trépanier J, Brassard A, René L, Cayer M, Mérette C, Maziade M, Roy MA. Fine motor dexterity is correlated to social functioning in schizophrenia. Schizophrenia Research. 62: 269-73. PMID 12837524 DOI: 10.1016/S0920-9964(02)00327-4  0.192
2001 Roy M, Mérette C, Maziade M. Introduction à la psychiatrie génétique: progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques The Canadian Journal of Psychiatry. 46: 52-60. PMID 11221490 DOI: 10.1177/070674370104600108  0.192
2021 Lesage A, Courteau J, Brodeur S, Stip E, Fleury MJ, Courteau M, Roy MA, Vanasse A. Urbanicity, Schizophrenia and Equitable Specialist Services Allocation. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437211040606. PMID 34482764 DOI: 10.1177/07067437211040606  0.19
2023 Huot-Lavoie M, Desmeules C, Corbeil O, Béchard L, Brodeur S, Essiambre AM, Thériault C, Anderson E, Bachand L, Haider ZA, Abdel-Baki A, Khazaal Y, Giroux I, Demers MF, Roy MA. Impact of gaming disorder on first episode psychosis patients' evolution: Protocol for a multicentered prospective study. Early Intervention in Psychiatry. PMID 38059702 DOI: 10.1111/eip.13482  0.182
2022 Roy MA, Olivier D, Cambon A. [From Kraepelin to McGorry: Scientific Vision and Experiential Narrative around a Major Paradigmatic Shift]. Sante Mentale Au Quebec. 46: 23-43. PMID 35617493  0.176
2024 Zaher F, Diallo M, Achim AM, Joober R, Roy MA, Demers MF, Subramanian P, Lavigne KM, Lepage M, Gonzalez D, Zeljkovic I, Davis K, Mackinley M, Sabesan P, Lal S, et al. Speech markers to predict and prevent recurrent episodes of psychosis: A narrative overview and emerging opportunities. Schizophrenia Research. 266: 205-215. PMID 38428118 DOI: 10.1016/j.schres.2024.02.036  0.172
2022 Cloutier B, Diotte F, Murphy C, Roy MA, Abdel-Baki A, Lepage M, Lecomte T. Evaluating romantic and sexual functioning among persons with psychosis: Reliability and validity of two measures. Psychiatric Rehabilitation Journal. PMID 36326644 DOI: 10.1037/prj0000544  0.167
2023 McKee KA, Crocker CE, Dikaios K, Otter N, Bardell A, Roy MA, Abdel-Baki A, Palaniyappan L, Malla A, Tibbo PG. Short communication: Prevalence of long-acting injectable antipsychotic use in Canadian early intervention services for psychosis. Journal of Psychiatric Research. 165: 77-82. PMID 37480668 DOI: 10.1016/j.jpsychires.2023.07.005  0.161
2012 Künzel T, Strauch K, Ma J, Xiao F, Xiong M, Andrew AS, Brenner H, Duell EJ, Haugen A, Hoggart C, Hung RJ, Lazarus P, Liu C, Matsuo K, Mayordomo JI, ... ... Roy M, et al. Contents Vol. 73, 2012 Human Heredity. 73. DOI: 10.1159/000342956  0.158
2009 Hein R, Beckmann L, Chang-Claude J, Bureau A, Mérette C, Croteau J, Fournier A, Chagnon YC, Roy M, Maziade M, Ekstrøm CT, Bergemann TL, Huang Z, Cheng KF, Lin WJ, et al. Contents Vol. 68, 2009 Human Heredity. 68. DOI: 10.1159/000243574  0.158
2022 Béchard L, Corbeil O, Malenfant E, Lehoux C, Stip E, Roy MA, Demers MF. [Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery]. Sante Mentale Au Quebec. 46: 113-137. PMID 35617496  0.157
2022 Huot-Lavoie M, Gabriel-Courval M, Béchard L, Corbeil O, Brodeur S, Massé C, Fournier É, Essiambre AM, Anderson E, Cayouette A, Giroux I, Khazaal Y, Demers MF, Roy MA. Gaming Disorder and Psychotic Disorders: A Scoping Review. Psychopathology. 1-9. PMID 36318899 DOI: 10.1159/000527143  0.156
2022 Malla A, Roy MA, Abdel-Baki A, Conus P, McGorry P. [Early Intervention for Psychosis from Past to Future: Overcoming Implementation Challenges to Maximize its Impact?] Sante Mentale Au Quebec. 46: 391-415. PMID 35617506  0.147
2024 Béchard L, Desmeules C, Bachand L, Huot-Lavoie M, Corbeil O, Anderson E, Brodeur S, LeBlanc A, Demers MF, Lauzier S, Roy MA. The Effects of Antipsychotic Discontinuation or Maintenance on the Process of Recovery in Remitted First-Episode Psychosis Patients - A Systematic Review and Meta-Analysis of Randomized Controlled Trials. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-34. PMID 38250810 DOI: 10.1192/j.eurpsy.2024.5  0.145
2020 Pothier W, Roy MA, Corbière M, Thibaudeau É, Achim AM, Wykes T, Reeder C, Chagnon Y, Cellard C. Personalized cognitive remediation therapy to facilitate return to work or to school in recent-onset psychosis. Neurocase. 1-13. PMID 33119429 DOI: 10.1080/13554794.2020.1841797  0.136
2021 Corbeil O, Corbeil S, Dorval M, Carmichael PH, Giroux I, Jacques C, Demers MF, Roy MA. Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program. Cns Drugs. PMID 33713298 DOI: 10.1007/s40263-021-00801-4  0.132
2022 Kuzo N, Haen E, Ho DM, Takeuchi H, Piras M, Eap CB, de Filippis R, Homan P, Kane JM, Roy MA, Paulzen M, Schoretsanitis G. Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience. PMID 36580106 DOI: 10.1007/s00406-022-01542-1  0.131
2013 Iyer S, Banks N, Roy MA, Tibbo P, Williams R, Manchanda R, Chue P, Malla A. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 58: 14S-22S. PMID 23945063  0.129
2022 Schöttle D, Clerzius G, Janetzky W, Oluboka O, Roy MA, Therrien F, Wiedemann K. Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies. European Psychiatry : the Journal of the Association of European Psychiatrists. 65: e42. PMID 35855645 DOI: 10.1192/j.eurpsy.2022.27  0.128
2023 Coronado-Montoya S, Abdel-Baki A, Côté J, Crockford D, Dubreucq S, Fischer B, Lachance-Touchette P, Lecomte T, L'Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo P, Villeneuve M, Wittevrongel A, et al. Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. Jmir Research Protocols. 12: e53094. PMID 38109196 DOI: 10.2196/53094  0.124
2024 Morin MH, Moreau A, Proulx M, Levasseur MA, Vigneault L, Gilbert M, Roy MA. [Sharing information and respecting confidentiality: Standards for improving the quality of mental health services]. Sante Mentale Au Quebec. 48: 151-177. PMID 38578188  0.12
2024 Coronado-Montoya S, Abdel-Baki A, Crockford D, Côté J, Dubreucq S, Dyachenko A, Fischer B, Lecomte T, L'Heureux S, Ouellet-Plamondon C, Roy MA, Tibbo P, Villeneuve M, Jutras-Aswad D. Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437241242395. PMID 38571478 DOI: 10.1177/07067437241242395  0.12
2024 L'Heureux S, Huot-Lavoie M, Bergeron A, Bergeron C, Blouin BP, Roy MA. Effect of Cannabis Legalization in Canada on the Incidence of Psychosis Consultations in Quebec City's Psychiatric Emergency Services. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437241232901. PMID 38380880 DOI: 10.1177/07067437241232901  0.12
2014 Bureau A, Croteau J, Chagnon YC, Roy MA, Maziade M. Extension of the generalized disequilibrium test to polytomous phenotypes and two-locus models. Frontiers in Genetics. 5: 258. PMID 25152751 DOI: 10.3389/fgene.2014.00258  0.119
2023 Corbeil O, Soulard M, Huot-Lavoie M, Béchard L, Fournier É, Brodeur S, Essiambre AM, Desmeules C, Thériault C, Abdel-Baki A, Jacques C, Giroux I, Dorval M, Roy MA, Demers MF. Problem gambling among people with first-episode psychosis: protocol for a prospective multicenter cohort study. Bmc Psychiatry. 23: 287. PMID 37098506 DOI: 10.1186/s12888-023-04741-9  0.118
2020 Ferraro V, Lafrenière S, Demers MF, Roy MA, Abdel-Baki A. "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients. Psychopharmacology. PMID 32978648 DOI: 10.1007/s00213-020-05656-z  0.117
2023 Tatar O, Abdel-Baki A, Dyachenko A, Bakouni H, Bahremand A, Tibbo PG, Crockford D, Roy MA, Copeland J, Fischer B, Lecomte T, Côté J, Ouellet-Plamondon C, L'Heureux S, Villeneuve M, et al. Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study. Psychiatry Research. 326: 115276. PMID 37301021 DOI: 10.1016/j.psychres.2023.115276  0.108
2022 Tatar O, Abdel-Baki A, Wittevrongel A, Lecomte T, Copeland J, Lachance-Touchette P, Coronado-Montoya S, Côté J, Crockford D, Dubreucq S, L'Heureux S, Ouellet-Plamondon C, Roy MA, Tibbo PG, Villeneuve M, et al. Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC). Jmir Research Protocols. 11: e40817. PMID 36427227 DOI: 10.2196/40817  0.105
2022 Roy L, Abdel-Baki A, Bérubé FA, Crocker A, de Benedictis L, Dostie M, Latimer E, Roy MA. Housing trajectories and the risk of homelessness among new mental health service users: Protocol for the AMONT study. Early Intervention in Psychiatry. 17: 495-501. PMID 37156495 DOI: 10.1111/eip.13344  0.104
2024 Roy L, Leclair M, Crocker AG, Abdel-Baki A, de Benedictis L, Bérubé FA, Thibeault E, Latimer E, Roy MA. Risk factors for homelessness and housing instability in the first episode of mental illness: Initial findings from the AMONT study. Early Intervention in Psychiatry. PMID 38353025 DOI: 10.1111/eip.13495  0.098
2023 Corbeil O, Béchard L, Fournier É, Plante M, Thivierge MA, Lafrenière CÉ, Huot-Lavoie M, Brodeur S, Essiambre AM, Roy MA, Demers MF. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review. Journal of Psychopharmacology (Oxford, England). 2698811231154111. PMID 36794520 DOI: 10.1177/02698811231154111  0.098
2023 Levesque P, Desmeules C, Béchard L, Huot-Lavoie M, Demers MF, Roy MA, Deslauriers J. Sex-specific immune mechanisms in PTSD symptomatology and risk: A translational overview and perspectives. Brain Research Bulletin. 195: 120-129. PMID 36822271 DOI: 10.1016/j.brainresbull.2023.02.013  0.094
2021 Kryshtalskyj MT, Roy M. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population. Ocular Immunology and Inflammation. 1-7. PMID 33621146 DOI: 10.1080/09273948.2020.1849737  0.088
2022 Morin MH, Bergeron AS, Levasseur MA, Iyer SN, Roy MA. [Family Approaches in Early Intervention: Benchmarks to Guide Intervention and Support Families in First Episode Psychosis Programs (FEPP)]. Sante Mentale Au Quebec. 46: 139-159. PMID 35617497  0.086
2022 Romain AJ, Bernard P, Piché F, Kern L, Ouellet-Plamondon C, Abdel-Baki A, Roy MA. [A Healthy Mind in a Healthy Body: The Value of Physical Activity for Youth With First Episode Psychosis]. Sante Mentale Au Quebec. 46: 249-276. PMID 35617501  0.085
2021 Alam MT, Alam QS, Alam MK, Islam MA, Saha MK, Rahman MM, Hossain MZ, Roy MK, Islam MK, Hossain M, Haque AN, Minto MR. Core Decompression with Non Vascularized Fibular Graft as Modern Surgical Treatment of Early Hip Avascular Necrosis. Mymensingh Medical Journal : Mmj. 30: 323-328. PMID 33830109  0.079
2022 LeBlanc A, Baron M, Blouin P, Tarabulsy G, Routhier F, Mercier C, Despres JP, Hébert M, De Koninck Y, Cellard C, Collin-Vézina D, Côté N, Dionne É, Fleet R, Gagné MH, ... ... Roy MA, et al. For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol. Bmj Open. 12: e048749. PMID 35379610 DOI: 10.1136/bmjopen-2021-048749  0.069
2020 Stip E, Grignon S, Roy MA, Bloom D, Osman O, Amiri L, Abdul Aziz K, Javaid SF, Arnone D. From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs). Expert Review of Neurotherapeutics. PMID 32962466 DOI: 10.1080/14737175.2020.1826930  0.068
2021 Bhuiyan MAN, Ryan P, Oroumyeh F, Jathan Y, Roy M, Balachandran S, Brokamp C. Source-specific contributions of particulate matter to asthma-related pediatric emergency department utilization. Health Information Science and Systems. 9: 12. PMID 33786161 DOI: 10.1007/s13755-021-00141-z  0.065
2021 Roy M, Purington N, Liu M, Blayney DW, Kurian AW, Schapira L. Limited English Proficiency and Disparities in Health Care Engagement Among Patients With Breast Cancer. Jco Oncology Practice. OP2001093. PMID 33844591 DOI: 10.1200/OP.20.01093  0.059
2021 Boucoiran I, Roy M, Poliquin V, Elwood C, Sheehan NL, Thibaudeau R, Ferreira E, Autmizguine J, Kakkar F, Boucher M, Money D, Tulloch K. Evaluation of cabergoline for lactation inhibition in women living with HIV. International Journal of Std & Aids. 956462420984694. PMID 33612017 DOI: 10.1177/0956462420984694  0.059
2021 Livingston NA, Simpson T, Lehavot K, Ameral V, Brief DJ, Enggasser J, Litwack S, Helmuth E, Roy M, Rosenbloom D, Keane TM. Differential alcohol treatment response by gender following use of VetChange. Drug and Alcohol Dependence. 221: 108552. PMID 33556659 DOI: 10.1016/j.drugalcdep.2021.108552  0.059
2021 Neal JW, Roy M, Bugos K, Sharp C, Galatin PS, Falconer P, Rosenthal EL, Blayney DW, Modaressi S, Robinson A, Ramchandran K. Distress Screening Through Patient-Reported Outcomes Measurement Information System (PROMIS) at an Academic Cancer Center and Network Site: Implementation of a Hybrid Model. Jco Oncology Practice. OP2000473. PMID 33830852 DOI: 10.1200/OP.20.00473  0.058
2022 Ferrari M, Iyer S, LeBlanc A, Roy MA, Abdel-Baki A. A Rapid-Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Protocol. Jmir Research Protocols. 11: e37346. PMID 35852849 DOI: 10.2196/37346  0.056
2021 Roy M, Dutta TK. Evaluation of Phytochemicals and Bioactive Properties in Mangrove Associate . ex J.F.Gmel. of Indian Sundarbans. Frontiers in Pharmacology. 12: 584019. PMID 33790782 DOI: 10.3389/fphar.2021.584019  0.056
2021 Patricio P, Roy JS, Macedo L, Roy M, Léonard G, Hodges P, Massé-Alarie H. Repetitive transcranial magnetic stimulation alone and in combination with motor control exercise for the treatment of individuals with chronic non-specific low back pain (ExTraStim trial): study protocol for a randomised controlled trial. Bmj Open. 11: e045504. PMID 33762244 DOI: 10.1136/bmjopen-2020-045504  0.053
1995 Shriqui C, Annable L, Bouchard G, Grondin P, Dufour M, Roy M. Tardive dyskinesia (TD) in schizophrenic subjects: A controlled magnetic resonance imaging (MRI) study Schizophrenia Research. 15: 210. DOI: 10.1016/0920-9964(95)95645-P  0.051
2010 Socransky SJ, Wiss R, Robins R, Anawati A, Roy MA, Yeung IC. Defining normal jugular venous pressure with ultrasonography. Cjem. 12: 320-4. PMID 20650024  0.051
2021 Mechai S, Bilodeau G, Lung O, Roy M, Steeves R, Gagne N, Baird D, Lapen DR, Ludwig A, Ogden NH. Mosquito Identification From Bulk Samples Using DNA Metabarcoding: a Protocol to Support Mosquito-Borne Disease Surveillance in Canada. Journal of Medical Entomology. PMID 33822118 DOI: 10.1093/jme/tjab046  0.05
2021 Ravitsky V, Roy MC, Haidar H, Henneman L, Marshall J, Newson AJ, Ngan OMY, Nov-Klaiman T. The Emergence and Global Spread of Noninvasive Prenatal Testing. Annual Review of Genomics and Human Genetics. PMID 33848430 DOI: 10.1146/annurev-genom-083118-015053  0.05
2022 Béchard L, Giroux I, Corbeil O, Plante M, Roy MA, Demers MF. Treating Depression Following Biliopancreatic Diversion With Duodenal Switch Surgery: A Case Report. Journal of Clinical Psychopharmacology. 42: 215-217. PMID 35230050 DOI: 10.1097/JCP.0000000000001504  0.048
2021 Roy M, Hansen P, Sullivan T, Ombler F, Kiore M, Stapleton A, Carr C. Rapid Development of a Tool for Prioritizing Patients with Coronavirus Disease 2019 for Intensive Care. Critical Care Explorations. 3: e0368. PMID 33786444 DOI: 10.1097/CCE.0000000000000368  0.048
2021 Biswas S, Mahapatra E, Ghosh A, Das S, Roy M, Mukherjee S. Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention : Apjcp. 22: 957-970. PMID 33773562 DOI: 10.31557/APJCP.2021.22.3.957  0.043
2004 Roy MA, Doherty TJ. Reliability of hand-held dynamometry in assessment of knee extensor strength after hip fracture. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 83: 813-8. PMID 15502733 DOI: 10.1097/01.PHM.0000143405.17932.78  0.041
2021 Roy M, Kubacki J, Psiuk B, Mrozek-Wilczkiewicz A, Malarz K, Corti A, Pompella A, Szade J. Photofunctionalization effect and biological ageing of PEEK, TiO and ZrO abutments material. Materials Science & Engineering. C, Materials For Biological Applications. 121: 111823. PMID 33579466 DOI: 10.1016/j.msec.2020.111823  0.039
2020 Singh S, Singh UB, Trivdi M, Malviya D, Sahu PK, Roy M, Sharma PK, Singh HV, Manna MC, Saxena AK. Restructuring the Cellular Responses: Connecting Microbial Intervention With Ecological Fitness and Adaptiveness to the Maize ( L.) Grown in Saline-Sodic Soil. Frontiers in Microbiology. 11: 568325. PMID 33643224 DOI: 10.3389/fmicb.2020.568325  0.039
2015 Roy MA, Dhanaraman T, D'Amours D. The Smc5-Smc6 heterodimer associates with DNA through several independent binding domains. Scientific Reports. 5: 9797. PMID 25984708 DOI: 10.1038/srep09797  0.037
2021 Alzahrani HS, Khuu SK, Roy M. Modelling the effect of light through commercially available blue-blocking lenses on the human circadian system. Clinical & Experimental Optometry. 1-6. PMID 33779493 DOI: 10.1080/08164622.2021.1898276  0.036
2021 Wauchope S, Roy MA, Irvine W, Morrison I, Brantley E, Gossell-Williams M, Timme-Laragy AR, Delgoda R. Dibenzyl trisulfide binds to and competitively inhibits the cytochrome P450 1A1 active site without impacting the expression of aryl hydrocarbon receptor. Toxicology and Applied Pharmacology. 115502. PMID 33774063 DOI: 10.1016/j.taap.2021.115502  0.036
2014 Laflamme G, Tremblay-Boudreault T, Roy MA, Andersen P, Bonneil É, Atchia K, Thibault P, D'Amours D, Kwok BH. Structural maintenance of chromosome (SMC) proteins link microtubule stability to genome integrity. The Journal of Biological Chemistry. 289: 27418-31. PMID 25135640 DOI: 10.1074/Jbc.M114.569608  0.034
2021 Vasiyani H, Shinde A, Roy M, Mane M, Singh K, Singh J, Gohel D, Currim F, Vaidya K, Chhabria M, Singh R. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells. Apoptosis : An International Journal On Programmed Cell Death. PMID 33840002 DOI: 10.1007/s10495-021-01669-x  0.033
2021 Mondal PK, Roy M. Spreadsheet analysis of the field driven start-up flow in a microfluidic channel. Electrophoresis. PMID 33856072 DOI: 10.1002/elps.202100038  0.033
2021 Pal M, Ramu V, Musib D, Kunwar A, Biswas A, Roy M. Iron(III) Complex-Functionalized Gold Nanocomposite as a Strategic Tool for Targeted Photochemotherapy in Red Light. Inorganic Chemistry. PMID 33887143 DOI: 10.1021/acs.inorgchem.1c00001  0.031
2011 Roy MA, Siddiqui N, D'Amours D. Dynamic and selective DNA-binding activity of Smc5, a core component of the Smc5-Smc6 complex. Cell Cycle (Georgetown, Tex.). 10: 690-700. PMID 21293191 DOI: 10.4161/cc.10.4.14860  0.03
2008 Korner-Bitensky N, Roy MA, Teasell R, Kloda L, Storr C, Asseraf-Pasin L, Menon A. Creation and pilot testing of StrokEngine: a stroke rehabilitation intervention website for clinicians and families. Journal of Rehabilitation Medicine. 40: 329-33. PMID 18461256 DOI: 10.2340/16501977-0177  0.03
2021 Roy MG, Davies LA, Guillen DE, Sequitin JD, Buchanan EP, Maricevich RS, Truong TA, Monson LA. Cleft Care Packages and the Impact on Postoperative Care Following a Primary Cleft Lip Repair. The Journal of Craniofacial Surgery. PMID 33606437 DOI: 10.1097/SCS.0000000000007561  0.026
2020 Singh N, Kumar D, Yadav G, Srivastava MK, Mishra SR, Gupta AK, Jauhari S, Roy MS. Comparison of Quality of Life and Bone Mass Density among Postmenopausal Women: A Cross-sectional Study. Journal of Mid-Life Health. 11: 224-230. PMID 33767563 DOI: 10.4103/jmh.JMH_107_20  0.025
2021 Roy MMD, Baird SR, Dornsiepen E, Paul LA, Miao L, Ferguson MJ, Zhou Y, Siewert I, Rivard E. A Stable Homoleptic Divinyl Tetrelene Series. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 33848023 DOI: 10.1002/chem.202100969  0.025
2022 Roy MA, Abdel-Baki A. Intervenir auprès des jeunes atteints de premier épisode psychotique : un recueil de savoirs et d’expériences en francophonie québécoise. Sante Mentale Au Quebec. 46: 19-21. PMID 35617492  0.024
2021 Maurya RP, Prajapat MK, Singh VP, Roy M, Todi R, Bosak S, Singh SK, Chaudhary S, Kumar A, Morekar SR. Serum Malondialdehyde as a Biomarker of Oxidative Stress in Patients with Primary Ocular Carcinoma: Impact on Response to Chemotherapy. Clinical Ophthalmology (Auckland, N.Z.). 15: 871-879. PMID 33664564 DOI: 10.2147/OPTH.S287747  0.023
2021 Roy MP. Comment on "Impact of Shutdown due to COVID-19 Pandemic on Aerosol Characteristics in Kanpur, India". Journal of Health & Pollution. 11: 210313. PMID 33815910 DOI: 10.5696/2156-9614-11.29.210313  0.022
2011 Roy MA, D'Amours D. DNA-binding properties of Smc6, a core component of the Smc5-6 DNA repair complex. Biochemical and Biophysical Research Communications. 416: 80-5. PMID 22086171 DOI: 10.1016/j.bbrc.2011.10.149  0.019
2020 Iorio-Morin C, Gahide G, Morin C, Vanderweyen D, Roy MA, St-Pierre I, Massicotte-Tisluck K, Fortin D. Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort. Frontiers in Oncology. 10: 543648. PMID 33552946 DOI: 10.3389/fonc.2020.543648  0.018
2021 Roy MJ, Vom A, Okamoto T, Smith BJ, Birkinshaw RW, Yang H, Abdo H, White CA, Segal D, Huang DCS, Baell JB, Colman PM, Czabotar PE, Lessene G. Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-X and BCL-2. Journal of Medicinal Chemistry. PMID 33904752 DOI: 10.1021/acs.jmedchem.0c01771  0.018
2021 Farris AR, Mann G, Parks J, Arrowood J, Roy M, Misyak S. School Nutrition Director Perceptions of Flexible Regulations for School Nutrition Programs in One Southeastern State. The Journal of School Health. PMID 33665846 DOI: 10.1111/josh.13002  0.013
Hide low-probability matches.